Ernexa Therapeutics Inc. Sale of Stock, Price Per Share
Ernexa Therapeutics Inc. (ERNA) had Sale of Stock, Price Per Share of $4.50 per share as of 2018-06-30, per its 10-K filed 2020-03-19.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2020-03-19
- 2018-06-30: Sale of Stock, Price Per Share $4.50.
- 2018-06-27: Sale of Stock, Price Per Share $4.50.
- 2017-04-30: Sale of Stock, Price Per Share $7.78.
- 2017-03-31: Sale of Stock, Price Per Share $7.85.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2018-06-30 | $4.50 10-K · filed 2020-03-19 |
| 2018-06-27 | $4.50 10-Q · filed 2018-08-06 |
| 2017-04-30 | $7.78 10-K · filed 2019-03-22 |
| 2017-03-31 | $7.85 10-K · filed 2019-03-22 |
| 2017-03-27 | $7.85 10-Q · filed 2017-05-04 |
| 2016-11-30 | $6.64 10-K · filed 2018-03-09 |
| 2016-11-02 | $6.64 10-K · filed 2017-03-09 |
| 2012-02-02 | $0.25 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |